Credo Health buys Affineon and relaunches as Pajama.ai for doctors' paperwork
Credo Health, a Denver company that pulls patient records before visits, acquired inbox-automation startup Affineon Health and renamed itself Pajama.ai. It sells AI that preps charts and clears routine inbox work for physicians.
Docket, covering health regulation and AI in care
, 2 min read
40 hoursMonthly time per physician Pajama.ai says it saves
What to know
- Credo Health acquired Affineon Health and relaunched as Pajama.ai at HLTH 2026; financial terms were not disclosed.
- The product combines Credo's pre-visit record retrieval with Affineon's tools for drafting lab-result notes and handling prescription renewals.
- Credo co-founder Carm Huntress stays CEO; Affineon CEO Evan Grossman becomes chief product officer.
Credo Health, a Denver company that gathers patients' medical records before appointments, has acquired Affineon Health, a startup that automates physicians' inbox work, and relaunched the combined business as Pajama.ai. The deal was announced on November 16 at the HLTH 2026 conference in Las Vegas, according to HIT Consultant. Financial terms were not disclosed.
The name refers to "pajama time," the after-hours work doctors do in the electronic health record (EHR) once clinic is over. HIT Consultant, citing federal data, reported that one in three family physicians spends three or more hours a day on that work.
What the product does
Pajama.ai joins two tools that sit at either end of a visit and work inside existing EHR workflows, according to HIT Consultant.
Before the visit, Credo's software pulls a patient's history from outside records and flags possible undiagnosed conditions, care gaps, overdue screenings, medication discrepancies and abnormal trends. After the visit, Affineon's layer drafts patient notifications for normal lab results, removes duplicate pharmacy renewal requests and clears routine inbox items.
The company says the combined product saves about 40 hours per physician each month. That figure is the company's own and no study behind it has been published. It is sold as a monthly subscription; no price was given.
Who runs it
Carm Huntress, Credo's co-founder, remains CEO. He previously founded Arrive Health, a real-time prescription benefit network. Evan Grossman, Affineon's CEO and a former athenahealth, Zus Health and Innovaccer executive, becomes chief product officer. HIStalk reported the same leadership arrangement.
HIT Consultant reported that existing customers include Peachtree Medical Center and San Marcos Family Medicine, whose chief operating officer said Affineon's automation cut inbox volume by more than half. That is a customer's account, not a measured result.
Regulation
Software that drafts messages and organizes records for clinicians to review generally sits outside FDA device rules, while tools that diagnose or recommend treatment can fall inside them. Flagging "undiagnosed conditions" is closer to that line; the company has not said whether any part of the product has been reviewed by the FDA. Our explainer on when AI scribes count as medical devices covers how that line is drawn.
Why it matters
Paperwork after hours is one of the most cited drivers of physician burnout, and inbox automation is becoming a crowded market as EHR vendors and AI companies add similar features. Pajama.ai is betting that combining work before and after the visit in one subscription gives small practices a reason to buy from a startup. It follows other HLTH-week deals and launches, including Inovalon's purchase of DrFirst, Wolters Kluwer's AgileMD deal and OpenAI's agents for health systems.
This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.
Sources
- Credo Health Acquires Affineon Health and Relaunches as Pajama.ai to Reclaim 40 Hours Per Physician Monthly, HIT Consultant, November 16, 2026
- News 11/18/26, HIStalk, November 17, 2026
Digital health and AI in careAI agents
Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.